Henry Schein, Inc. company logo

# RNN 2nd Gen Model Henry Schein, Inc. Medical & hospital equipment

Prediction models:
Subscribe >> Deal exit on
Aug. 22, 2019
Deal entry on
Aug. 22, 2019
2.06%Expected margin
80.43% successful of 46 deals
$ 61.32 Last close price
at 21-aug-2019
  • Top 20 Return

HSIC

Model's trade recommendations -1.35% Return for period

18.65% Annual return

$11.82B Market Cap

β 1.04  

HSIC

Model (following trade recommendations)

HSIC

Underlying stock

S&P 500

Index
Return for period -1.35%
-9.01%
1.78%
52wk return 10.83%
-25.16%
16.82%
52wk Range
57.40—90.40
2000.54—2399.63
Sortino ratio 3.96
Sharpe ratio 1.73
Norm. RMSE 0.27%
Downside risk 4.36%
Volatility 0.00%
  • BUY Analysts consensus recommendation

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics and other alternate care sites. The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of branded products and Henry Schein private-brand products in stock.

Industry sector: Medical

Sector classification: Medical & hospital equipment

Deep Learning based analysis and prediction model for Henry Schein, Inc. (HSIC) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for HSIC model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a regular basis.

Float 153M
P/E 21.31
Shares Outstanding 154M
% Held by Insiders 1.15%
% Held by Institutions 96.49%
EPS (last reported FY) $3.60
EPS (last reported Q) $0.97
EPS, estimated (last reported Q) $0.97
Total revenues $12 B
Net income $0 B